Showing results (301-310 of 776) with videos related to
Sort By:
Pageof 78
Thrombosis and Haemostasis|January 1, 1994
Prevalence and induction of circulating antibodies against recombinant staphylokinaseP J Declerck, S Vanderschueren, J Billiet, et al.Journal of Thrombosis and Haemostasis : JTH|June 29, 2007
Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in miceY Suzuki, N Nagai, K Umemura, et al.Circulation|July 1, 1991
Streptokinase-induced platelet aggregation. Prevalence and mechanismD E Vaughan, E Van Houtte, P J Declerck, et al.The Journal of Biological Chemistry|August 26, 1998
NH2-terminal structural motifs in staphylokinase required for plasminogen activationB Schlott, K H Gührs, M Hartmann, et al.The Journal of Biological Chemistry|July 3, 1999
Functional interactions between Sp1 or Sp3 and the helicase-like transcription factor mediate basal expression from the human plasminogen activator inhibitor-1 geneH Ding, A M Benotmane, G Suske, et al.Thrombosis and Haemostasis|December 1, 1996
Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activatorK Okada, H R Lijnen, H Moreau, et al.Thrombosis and Haemostasis|July 10, 1998
Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin systemH R Lijnen, J Silence, G Lemmens, et al.The Journal of Clinical Investigation|March 1, 1982
Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosisC Korninger, O Matsuo, R Suy, et al.The Journal of Biological Chemistry|February 28, 1997
Staphylokinase requires NH2-terminal proteolysis for plasminogen activationB Schlott, K H Gührs, M Hartmann, et al.Blood|September 1, 1992
Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis modelY Imura, J M Stassen, S Bunting, et al.Pageof 78